Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 23572490)

1.

Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.

Berwanger O, Cavalcanti AB, Sousa AM, Buehler A, Castello-Júnior HJ, Cantarelli MJ, Mangione JA, Bergo RR, São Thiago LE, Nunes PM, da Motta PA, Kodama A, Victor E, Carvalho VO, Sousa JE; Acetylcysteine for Contrast-Induced Nephropathy Trial Investigators.

Circ Cardiovasc Interv. 2013 Apr;6(2):139-45. doi: 10.1161/CIRCINTERVENTIONS.112.000149. Epub 2013 Apr 9.

3.
5.

Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).

Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, Kubacki T, Benzing T, Erdmann E, Burst V, Gassanov N.

Circulation. 2012 Jul 17;126(3):296-303. doi: 10.1161/CIRCULATIONAHA.112.096370. Epub 2012 Jun 26.

6.

Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.

Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G; REMEDIAL II Investigators.

Circulation. 2011 Sep 13;124(11):1260-9. doi: 10.1161/CIRCULATIONAHA.111.030759. Epub 2011 Aug 15.

8.

Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.

Rashid ST, Salman M, Myint F, Baker DM, Agarwal S, Sweny P, Hamilton G.

J Vasc Surg. 2004 Dec;40(6):1136-41.

PMID:
15622367
9.

N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.

Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.

Am Heart J. 2009 Mar;157(3):576-83. doi: 10.1016/j.ahj.2008.11.010. Epub 2009 Feb 6.

PMID:
19249432
10.

[Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].

Vallero A, Cesano G, Pozzato M, Garbo R, Minelli M, Quarello F, Formica M.

G Ital Nefrol. 2002 Sep-Oct;19(5):529-33. Italian.

PMID:
12439841
11.

Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?

Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X, Deteix P, Souweine B.

Clin Nephrol. 2008 Dec;70(6):475-84.

PMID:
19049703
12.

Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.

Calabrò P, Bianchi R, Crisci M, Caprile M, Bigazzi MC, Palmieri R, Golia E, De Vita A, Romano IJ, Limongelli G, Russo MG, Calabrò R.

Intern Emerg Med. 2011 Dec;6(6):503-7. doi: 10.1007/s11739-011-0513-y. Epub 2011 Jan 29.

PMID:
21279477
13.

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.

Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.

Eur Heart J. 2004 Feb;25(3):212-8. Review.

15.

Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.

Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:13-21.

16.

Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial.

Carbonell N, Blasco M, Sanjuán R, Pérez-Sancho E, Sanchis J, Insa L, Bodí V, Núñez J, García-Ramón R, Miguel A.

Int J Cardiol. 2007 Jan 31;115(1):57-62. Epub 2006 Jun 30.

PMID:
16814414
17.

Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.

Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ.

JAMA. 2008 Sep 3;300(9):1038-46. doi: 10.1001/jama.300.9.1038.

PMID:
18768415
18.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
20.

Prevention of contrast-induced nephropathy in vascular surgery patients.

Lawlor DK, Moist L, DeRose G, Harris KA, Lovell MB, Kribs SW, Elliot J, Forbes TL.

Ann Vasc Surg. 2007 Sep;21(5):593-7.

PMID:
17823041
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk